Success Stories: Pushing Precision Forward: EB2-NIW Approved for Analytical Chemist Transforming Mass Spectrometry

Client’s Testimonial:

“Attorneys from Wegreened demonstrated a high level of professionalism in my NIW petition.”

On May 22^nd, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Scientist in the Field of Analytical Chemistry (Approval Notice).

General Field: Analytical Chemistry

Position at the Time of Case Filing: Scientist

Country of Origin: China

State of Residence at the Time of Filing: California

Approval Notice Date: May 22^nd, 2025

Processing Time: 1 month, 24 days (Premium Processing Requested)

Case Summary:

We are pleased to announce the EB2-NIW (National Interest Waiver) approval of a Chinese analytical chemist whose work is revolutionizing the field of mass spectrometry. With a focus on developing advanced mass spectrometers for biological analyte analysis, her contributions are empowering breakthroughs in biomedical research, pharmaceutical development, and structural biology.

Engineering Analytical Power for the Molecular Frontier

The client’s research centers on advancing the hardware and control systems of mass spectrometry instruments to expand their accessibility, performance, and cost efficiency. By applying her distinguished talent in ion trajectory simulations and instrumentation designs, she has developed innovative tools for the analysis of large biomolecules, enabling high-mass ion detection that was previously limited by cost and resolution.

Her current work as a scientist in the research and development division of a major biotech company focuses on optimizing the performance of a type of high-end mass spectrometer and expanding the application of mass spectrometry in the field of biotechnology. Her goal is to make these high-end analytical techniques more versatile and cost-effective, especially for applications in high-throughput analysis of biological samples.

A Robust Record of Research Excellence

She has authored 3 peer-reviewed journal articles, including two first-authored papers, and 3 conference abstracts, and her work has been cited 17 times in prominent publications. At least one of her papers ranks among the top 10% most cited in the field of Chemistry for its publication year. Her research appears in respected journals in the field of mass spectrometry.

Beyond authorship, she has developed a unique custom-built mass spectrometer that can conduct various types of tandem mass spectrometry analysis on high-mass biomolecules, which have garnered attention from researchers worldwide, who have cited her work in areas ranging from protein complex analysis to instrumentation optimization.

Advancing Drug Discovery with Precision Tools

One of her most acclaimed projects focused on creating a cost-effective mass analyzer that accurately analyzes large biomolecules that yield high-mass-to-charge (m/z) ions and reveals their structures. As highlighted in a letter from a professor at an esteemed public university:

“Her work enables faster, more precise structural analysis of large biomolecules at reduced cost, directly improving the accessibility of advanced diagnostic tools for hospitals and laboratories. [Client]’s research is integral to the U.S. and its ability to improve the productivity of its pharmaceutical industry.”

By improving analytical resolution while lowering financial barriers, her systems offer transformative potential for clinical and research applications. Her work facilitates high-m/z biomolecular structure analysis critical to therapeutic development, personalized medicine, and proteomics.

National Funding and Global Impact

Her research has earned support from the National Institutes of Health (NIH), reflecting the federal government’s recognition of its national relevance. NIH funding is reserved for studies that advance public health, biomedical innovation, and long-term scientific capability—all of which are core to her contributions.

Colleagues from North America and Asia have cited her work to develop better oscillator models, optimize digital waveform traps, and scale ion parking technologies. Her impact spans academia and industry, from instrumentation design to real-world medical analysis.

Rapid Approval Reflects National Significance

Filed on March 28, 2025, and approved on May 22, 2025, under premium processing, her EB2-NIW petition met the high evidentiary bar for national interest. The case demonstrated not only her innovation in analytical hardware but also her leadership in translating those innovations into usable tools for pharmaceutical and life sciences applications.

We are honored to support pioneering minds like this client, who push the boundaries of science through elegant engineering. Her story exemplifies how analytical precision and creativity can empower discovery, reduce costs, and shape a more innovative future for health and research.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.